PAD patients with critical limb ischemia (CLI) have been shown to have elevated formation of ROS, assessed by chemiluminescence using the luminol analogue L-012, in addition to increased levels of serum sTREM-1 and a higher expression of TREM-1 on PMN [72]. This evidence concerns the gene TREM1 and peripheral arterial disease.